Logo image of CRAYN.OL

CRAYON GROUP HOLDING AS (CRAYN.OL) Stock Fundamental Analysis

OSL:CRAYN - Euronext Oslo - NO0010808892 - Common Stock - Currency: NOK

125.4  +1.4 (+1.13%)

Fundamental Rating

5

CRAYN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 97 industry peers in the Software industry. While CRAYN is still in line with the averages on profitability rating, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on CRAYN.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CRAYN was profitable.
In the past year CRAYN had a positive cash flow from operations.
CRAYN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CRAYN had a positive operating cash flow.
CRAYN.OL Yearly Net Income VS EBIT VS OCF VS FCFCRAYN.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of 1.31%, CRAYN is in line with its industry, outperforming 49.48% of the companies in the same industry.
The Return On Equity of CRAYN (8.68%) is comparable to the rest of the industry.
With an excellent Return On Invested Capital value of 11.38%, CRAYN belongs to the best of the industry, outperforming 85.57% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CRAYN is below the industry average of 10.77%.
The last Return On Invested Capital (11.38%) for CRAYN is above the 3 year average (8.15%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.31%
ROE 8.68%
ROIC 11.38%
ROA(3y)0.27%
ROA(5y)0.94%
ROE(3y)1.7%
ROE(5y)5.34%
ROIC(3y)8.15%
ROIC(5y)8.32%
CRAYN.OL Yearly ROA, ROE, ROICCRAYN.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

CRAYN has a Profit Margin (3.67%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CRAYN has declined.
CRAYN has a Operating Margin of 11.42%. This is in the better half of the industry: CRAYN outperforms 64.95% of its industry peers.
In the last couple of years the Operating Margin of CRAYN has grown nicely.
CRAYN has a better Gross Margin (89.62%) than 89.69% of its industry peers.
In the last couple of years the Gross Margin of CRAYN has grown nicely.
Industry RankSector Rank
OM 11.42%
PM (TTM) 3.67%
GM 89.62%
OM growth 3Y-1%
OM growth 5Y62.81%
PM growth 3Y-16.95%
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y46.49%
CRAYN.OL Yearly Profit, Operating, Gross MarginsCRAYN.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRAYN is still creating some value.
Compared to 1 year ago, CRAYN has more shares outstanding
The number of shares outstanding for CRAYN has been increased compared to 5 years ago.
The debt/assets ratio for CRAYN has been reduced compared to a year ago.
CRAYN.OL Yearly Shares OutstandingCRAYN.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CRAYN.OL Yearly Total Debt VS Total AssetsCRAYN.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

CRAYN has an Altman-Z score of 0.96. This is a bad value and indicates that CRAYN is not financially healthy and even has some risk of bankruptcy.
CRAYN has a Altman-Z score of 0.96. This is in the lower half of the industry: CRAYN underperforms 67.01% of its industry peers.
CRAYN has a debt to FCF ratio of 1.66. This is a very positive value and a sign of high solvency as it would only need 1.66 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 1.66, CRAYN is doing good in the industry, outperforming 71.13% of the companies in the same industry.
A Debt/Equity ratio of 0.55 indicates that CRAYN is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.55, CRAYN is doing worse than 62.89% of the companies in the same industry.
Although CRAYN does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 1.66
Altman-Z 0.96
ROIC/WACC1.2
WACC9.46%
CRAYN.OL Yearly LT Debt VS Equity VS FCFCRAYN.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

CRAYN has a Current Ratio of 0.99. This is a bad value and indicates that CRAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
CRAYN has a Current ratio of 0.99. This is in the lower half of the industry: CRAYN underperforms 69.07% of its industry peers.
A Quick Ratio of 0.99 indicates that CRAYN may have some problems paying its short term obligations.
With a Quick ratio value of 0.99, CRAYN is not doing good in the industry: 68.04% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.99
CRAYN.OL Yearly Current Assets VS Current LiabilitesCRAYN.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

5

3. Growth

3.1 Past

CRAYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 191.50%, which is quite impressive.
CRAYN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.95% yearly.
The Revenue has grown by 9.63% in the past year. This is quite good.
CRAYN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.43% yearly.
EPS 1Y (TTM)191.5%
EPS 3Y8.95%
EPS 5YN/A
EPS Q2Q%130.54%
Revenue 1Y (TTM)9.63%
Revenue growth 3Y25.66%
Revenue growth 5Y-12.43%
Sales Q2Q%2.11%

3.2 Future

Based on estimates for the next years, CRAYN will show a very strong growth in Earnings Per Share. The EPS will grow by 48.55% on average per year.
The Revenue is expected to decrease by -1.25% on average over the next years.
EPS Next Y108.12%
EPS Next 2Y65.95%
EPS Next 3Y48.55%
EPS Next 5YN/A
Revenue Next Year13.29%
Revenue Next 2Y13.92%
Revenue Next 3Y13.37%
Revenue Next 5Y-1.25%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CRAYN.OL Yearly Revenue VS EstimatesCRAYN.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
CRAYN.OL Yearly EPS VS EstimatesCRAYN.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 32.32, CRAYN can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CRAYN is valued a bit cheaper than 69.07% of the companies in the same industry.
CRAYN's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 24.29.
Based on the Price/Forward Earnings ratio of 15.54, the valuation of CRAYN can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRAYN indicates a rather cheap valuation: CRAYN is cheaper than 86.60% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.42, CRAYN is valued a bit cheaper.
Industry RankSector Rank
PE 32.32
Fwd PE 15.54
CRAYN.OL Price Earnings VS Forward Price EarningsCRAYN.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

78.35% of the companies in the same industry are more expensive than CRAYN, based on the Enterprise Value to EBITDA ratio.
91.75% of the companies in the same industry are more expensive than CRAYN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.49
EV/EBITDA 10.01
CRAYN.OL Per share dataCRAYN.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

CRAYN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CRAYN may justify a higher PE ratio.
CRAYN's earnings are expected to grow with 48.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y65.95%
EPS Next 3Y48.55%

0

5. Dividend

5.1 Amount

CRAYN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CRAYON GROUP HOLDING AS

OSL:CRAYN (5/6/2025, 7:00:00 PM)

125.4

+1.4 (+1.13%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-12 2025-02-12/bmo
Earnings (Next)05-21 2025-05-21
Inst Owners63.5%
Inst Owner ChangeN/A
Ins Owners0.82%
Ins Owner ChangeN/A
Market Cap11.23B
Analysts82.67
Price Target143.67 (14.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-37.27%
Min EPS beat(2)-60.61%
Max EPS beat(2)-13.94%
EPS beat(4)1
Avg EPS beat(4)-17.83%
Min EPS beat(4)-60.61%
Max EPS beat(4)34.11%
EPS beat(8)2
Avg EPS beat(8)-52.03%
EPS beat(12)3
Avg EPS beat(12)-63.05%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.71%
Min Revenue beat(2)-9.83%
Max Revenue beat(2)-9.59%
Revenue beat(4)1
Avg Revenue beat(4)-5.61%
Min Revenue beat(4)-9.83%
Max Revenue beat(4)1.05%
Revenue beat(8)4
Avg Revenue beat(8)-2.62%
Revenue beat(12)5
Avg Revenue beat(12)-20%
Revenue beat(16)5
Avg Revenue beat(16)-36.3%
PT rev (1m)0%
PT rev (3m)-5.62%
EPS NQ rev (1m)-11.15%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.6%
EPS NY rev (3m)-13.62%
Revenue NQ rev (1m)-2.24%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-2.72%
Valuation
Industry RankSector Rank
PE 32.32
Fwd PE 15.54
P/S 1.6
P/FCF 9.49
P/OCF 8.43
P/B 3.79
P/tB N/A
EV/EBITDA 10.01
EPS(TTM)3.88
EY3.09%
EPS(NY)8.07
Fwd EY6.43%
FCF(TTM)13.21
FCFY10.53%
OCF(TTM)14.88
OCFY11.87%
SpS78.29
BVpS33.06
TBVpS-10.97
PEG (NY)0.3
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.31%
ROE 8.68%
ROCE 16.82%
ROIC 11.38%
ROICexc 17.44%
ROICexgc N/A
OM 11.42%
PM (TTM) 3.67%
GM 89.62%
FCFM 16.87%
ROA(3y)0.27%
ROA(5y)0.94%
ROE(3y)1.7%
ROE(5y)5.34%
ROIC(3y)8.15%
ROIC(5y)8.32%
ROICexc(3y)11.91%
ROICexc(5y)28.33%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.05%
ROCE(5y)12.29%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y22.85%
ROICexc growth 5Y8.87%
OM growth 3Y-1%
OM growth 5Y62.81%
PM growth 3Y-16.95%
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y46.49%
F-Score6
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 1.66
Debt/EBITDA 1.42
Cap/Depr 44.51%
Cap/Sales 2.14%
Interest Coverage 2.69
Cash Conversion 117.14%
Profit Quality 460.31%
Current Ratio 0.99
Quick Ratio 0.99
Altman-Z 0.96
F-Score6
WACC9.46%
ROIC/WACC1.2
Cap/Depr(3y)45.9%
Cap/Depr(5y)48.63%
Cap/Sales(3y)2.42%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)191.5%
EPS 3Y8.95%
EPS 5YN/A
EPS Q2Q%130.54%
EPS Next Y108.12%
EPS Next 2Y65.95%
EPS Next 3Y48.55%
EPS Next 5YN/A
Revenue 1Y (TTM)9.63%
Revenue growth 3Y25.66%
Revenue growth 5Y-12.43%
Sales Q2Q%2.11%
Revenue Next Year13.29%
Revenue Next 2Y13.92%
Revenue Next 3Y13.37%
Revenue Next 5Y-1.25%
EBIT growth 1Y81.22%
EBIT growth 3Y24.41%
EBIT growth 5Y42.57%
EBIT Next Year59.64%
EBIT Next 3Y30.07%
EBIT Next 5YN/A
FCF growth 1Y-6.11%
FCF growth 3YN/A
FCF growth 5Y59.47%
OCF growth 1Y-5.66%
OCF growth 3Y272.45%
OCF growth 5Y47.49%